3B Blackbio

{
  "main_header": {
    "sid": 418147,
    "name": "3B Blackbio",
    "stock_name": "3B Blackbio",
    "full_name": "3B Blackbio DX Ltd",
    "name_url": "stocks-analysis/3b-blackbio",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,196.10",
    "chg": -5,
    "chgp": "-0.42%",
    "dir": -1,
    "prev_price": "1,201.10",
    "mcapval": "1,029.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532067,
    "symbol": "3BBLACKBIO",
    "ind_name": "Healthcare Services",
    "ind_code": 18,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE994E01018",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "03:38 AM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "26.72 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/3b-blackbio-418147-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "3B Blackbio DX Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-by-marketsmojo-4065150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_mojoScore_4065150.png",
        "date": "2026-06-20 10:10:16",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-faces-bearish-momentum-amid-technical-downgrade-4060343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_technicaldot_4060343.png",
        "date": "2026-06-18 08:01:45",
        "description": "3B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 23 March 2026. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price declining by 4.8% on 18 June 2026 to ₹1,204.05 from the previous close of ₹1,264.80."
      },
      {
        "title": "3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-technical-momentum-shifts-amid-mixed-market-signals-4045815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_technicaldot_4045815.png",
        "date": "2026-06-11 08:01:55",
        "description": "3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has recently experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a notable 4.00% gain on 11 Jun 2026, the stock’s technical indicators present a complex picture, reflecting mixed signals across various timeframes and metrics."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-4041003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_mojoScore_4041003.png",
        "date": "2026-06-09 10:10:21",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1083.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-falls-to-52-week-low-of-rs10835-amidst-market-downturn-4030207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_priceRelatedfactors_4030207.png",
        "date": "2026-06-02 09:42:30",
        "description": ""
      },
      {
        "title": "3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1090 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-falls-to-52-week-low-amid-market-pressure-4026808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_priceRelatedfactors_4026808.png",
        "date": "2026-06-01 15:05:31",
        "description": "A sharp decline in 3B Blackbio DX Ltd shares has pushed the stock to a fresh 52-week low of Rs 1090 on 1 Jun 2026, marking a significant 12.38% intraday drop amid heightened volatility. This fall comes despite recent quarterly profit growth, underscoring a complex interplay of valuation concerns and market sentiment weighing on the micro-cap healthcare services company."
      },
      {
        "title": "Are 3B Blackbio DX Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-3b-blackbio-dx-ltd-latest-results-good-or-bad-4023885",
        "imagepath": "",
        "date": "2026-05-30 19:49:52",
        "description": "The latest financial results for 3B Blackbio DX Ltd for the quarter ended March 2026 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹35.43 crores, reflecting a significant year-on-year growth of 57.47% compared to ₹22.50 crores in the same quarter last year. However, this growth was accompanied by a notable quarter-on-quarter decline of 29.63% from ₹50.35 crores in the previous quarter, indicating potential revenue volatility.\n\nIn terms of profitability, the consolidated net profit stood at ₹9.56 crores, which represents a year-on-year increase of 13.81% from ₹8.40 crores in the same quarter last year. Nonetheless, this figure marked a sharp decline of 56.01% compared to the previous quarter, raising concerns about the sustainability of profit levels. The profit after tax (PAT) margin contracted to 27.66%, down from ..."
      },
      {
        "title": "3B Blackbio DX Q4 FY26: Profit Plunge Overshadows Revenue Growth Amid Rising Costs",
        "link": "https://www.marketsmojo.com/news/result-analysis/3b-blackbio-dx-q4-fy26-profit-plunge-overshadows-revenue-growth-amid-rising-costs-4022732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDX_quaterlyResult_4022732.png",
        "date": "2026-05-29 22:18:56",
        "description": "3B Blackbio DX Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,064.00 crores, posted a sharp 56.01% quarter-on-quarter decline in consolidated net profit to ₹9.56 crores in Q4 FY26, despite reporting a robust 57.47% year-on-year revenue growth to ₹35.43 crores. The disappointing bottom-line performance was primarily driven by a dramatic surge in employee costs and a significant spike in depreciation expenses, which more than offset the company's top-line expansion."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-4019933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_mojoScore_4019933.png",
        "date": "2026-05-29 10:10:42",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 311,
    "sid": "418147",
    "stock_news_url": "https://www.marketsmojo.com/news/3b-blackbio-dx-418147"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

3B Blackbio DX Ltd is Rated Sell by MarketsMOJO

2026-06-20 10:10:16

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.

Read full news article

3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-06-18 08:01:45

3B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 23 March 2026. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price declining by 4.8% on 18 June 2026 to ₹1,204.05 from the previous close of ₹1,264.80.

Read full news article

3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-11 08:01:55

3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has recently experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a notable 4.00% gain on 11 Jun 2026, the stock’s technical indicators present a complex picture, reflecting mixed signals across various timeframes and metrics.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-06-09 10:10:21

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1083.5 as Sell-Off Deepens

2026-06-02 09:42:30

Read full news article

3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1090 as Sell-Off Deepens

2026-06-01 15:05:31

A sharp decline in 3B Blackbio DX Ltd shares has pushed the stock to a fresh 52-week low of Rs 1090 on 1 Jun 2026, marking a significant 12.38% intraday drop amid heightened volatility. This fall comes despite recent quarterly profit growth, underscoring a complex interplay of valuation concerns and market sentiment weighing on the micro-cap healthcare services company.

Read full news article

Are 3B Blackbio DX Ltd latest results good or bad?

2026-05-30 19:49:52

The latest financial results for 3B Blackbio DX Ltd for the quarter ended March 2026 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹35.43 crores, reflecting a significant year-on-year growth of 57.47% compared to ₹22.50 crores in the same quarter last year. However, this growth was accompanied by a notable quarter-on-quarter decline of 29.63% from ₹50.35 crores in the previous quarter, indicating potential revenue volatility. In terms of profitability, the consolidated net profit stood at ₹9.56 crores, which represents a year-on-year increase of 13.81% from ₹8.40 crores in the same quarter last year. Nonetheless, this figure marked a sharp decline of 56.01% compared to the previous quarter, raising concerns about the sustainability of profit levels. The profit after tax (PAT) margin contracted to 27.66%, down from ...

Read full news article

3B Blackbio DX Q4 FY26: Profit Plunge Overshadows Revenue Growth Amid Rising Costs

2026-05-29 22:18:56

3B Blackbio DX Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,064.00 crores, posted a sharp 56.01% quarter-on-quarter decline in consolidated net profit to ₹9.56 crores in Q4 FY26, despite reporting a robust 57.47% year-on-year revenue growth to ₹35.43 crores. The disappointing bottom-line performance was primarily driven by a dramatic surge in employee costs and a significant spike in depreciation expenses, which more than offset the company's top-line expansion.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-05-29 10:10:42

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

View All News